89bio, Inc. (ETNB)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

535 MISSION STREET SAN FRANCISCO, CA 94105

89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). 89bio is headquartered in San Francisco with operations in Herzliya, Israel.

Data as of 2021-07-25 17:43:40 -0400
Market Cap343.432 Million Shares Outstanding20.06 Million Avg 30-day Volume92.789 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.67 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.16019 52-week High/Low42.36 / 15.52 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -25.2412
Data provided by IEX Cloud
View SEC Filings from ETNB instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 1 (0.06%) 0 (0.0%)
Funds Holding: 67 69 -2.9% 24 (1.41%) 26 (1.51%) -7.69%
13F shares: 16.867 Million 16.717 Million 0.9% 12.205 Million 12.377 Million -1.39%
% Ownership 84.561 84.0929 0.56% 61.1914 62.2625 -1.72%
New Positions: 9 14 -35.71% 4 3 33.33%
Increased Positions 24 35 -31.43% 8 11 -27.27%
Closed Positions 11 12 -8.33% 6 5 20.0%
Reduced Positions 21 15 40.0% 8 9 -11.11%
Total Calls 22.305 Thousand 9.6 Thousand
Total Puts 20.201 Thousand 16.4 Thousand 23.18%
PUT/CALL Ratio 0.91 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ETNB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ETNB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

29.1 Thousand total shares from 3 transactions

Open Market Sells (S)

14 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

14 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WAISBOURD RAM SEE REMARKS

  • Officer
39,203 2021-07-16 10

PALEKAR ROHAN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
37,000 2021-07-07 2

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
4,965,769 2021-06-02 3

GRUNBERG GREGORY

  • Director
1,750,877 2021-04-21 3

MARTINS RYAN CHIEF FINANCIAL OFFICER

  • Officer
92,401 2021-04-19 2

DIROCCO DEREK

  • Director
12,500 2021-04-15 1

NASCHITZ ANAT

  • Director
  • 10% Owner
12,500 2021-04-15 2

HAYDEN MICHAEL R

  • Director
12,500 2021-04-15 2

ALTSCHULER STEVEN

  • Director
12,500 2021-04-15 1

ZOTH LOTA S.

  • Director
12,500 2021-04-15 1

LE-NGUYEN QUOC SEE REMARKS

  • Officer
10,000 2021-02-05 2

MANSBACH HARRY H CHIEF MEDICAL OFFICER

  • Officer
10,000 2021-02-05 1

LONGITUDE CAPITAL PARTNERS III, LLC

LONGITUDE VENTURE PARTNERS III, L.P.

TAMMENOMS BAKKER JULIET

ENRIGHT PATRICK G

  • 10% Owner
No longer subject to file 2020-11-16 1

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ORBIMED ADVISORS ISRAEL II LTD

ORBIMED ISRAEL GP II, L.P.

  • Director
  • 10% Owner
3,729,442 2020-09-21 1

KARIV TOMER

PONTIFAX (ISRAEL) V, L.P.

PONTIFAX (CAYMAN) V, L.P.

PONTIFAX (CHINA) V, L.P.

PONTIFAX 5 G.P. L.P.

PONTIFAX MANAGEMENT 4 G.P. (2015) LTD.

PONTIFAX LATE STAGE GP LTD.

PONTIFAX LATE STAGE FUND L.P.

  • Director
  • 10% Owner
1,134,671 2019-11-11 0

KARIV TOMER

PONTIFAX (ISRAEL) V, L.P.

PONTIFAX (CAYMAN) V, L.P.

PONTIFAX (CHINA) V, L.P.

PONTIFAX 5 G.P. L.P.

PONTIFAX MANAGEMENT 4 G.P. (2015) LTD.

  • Director
  • 10% Owner
0 2019-11-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

WAISBOURD RAM - Officer SEE REMARKS

2021-07-19 16:05:38 -0400 2021-07-16 M 7,000 d 39,203 direct

WAISBOURD RAM - Officer SEE REMARKS

2021-07-19 16:05:38 -0400 2021-07-16 S 7,000 $16.80 d 0 direct 1.0983 -11.9075 1.0983 2 -11.9075 6

WAISBOURD RAM - Officer SEE REMARKS

2021-07-19 16:05:38 -0400 2021-07-16 M 7,000 $1.93 a 7,000 direct 1.0983 -11.9075 1.0983 2 -11.9075 6

PALEKAR ROHAN - Director - Officer CHIEF EXECUTIVE OFFICER

2021-07-08 16:05:18 -0400 2021-07-08 P 2,000 $16.25 a 37,000 direct -5.981 -2.4595 0.0 1 -10.6764 4

PALEKAR ROHAN - Director - Officer CHIEF EXECUTIVE OFFICER

2021-07-08 16:05:18 -0400 2021-07-07 P 5,000 $17.07 a 35,000 direct -5.981 -2.4595 0.0 1 -10.6764 4

WAISBOURD RAM - Officer SEE REMARKS

2021-06-21 16:30:43 -0400 2021-06-16 S 7,000 $19.67 d 0 direct 1.7993 8.615 18.7023 4 0.0 1

WAISBOURD RAM - Officer SEE REMARKS

2021-06-21 16:30:43 -0400 2021-06-16 M 7,000 $1.93 a 7,000 direct 1.7993 8.615 18.7023 4 0.0 1

WAISBOURD RAM - Officer SEE REMARKS

2021-06-21 16:30:43 -0400 2021-06-16 M 7,000 d 46,203 direct

RA CAPITAL MANAGEMENT, L.P. - Director - > 10% Owner see footnote

RA CAPITAL HEALTHCARE FUND LP - Director - > 10% Owner see footnote

KOLCHINSKY PETER - Director - > 10% Owner see footnote

SHAH RAJEEV M. - Director - > 10% Owner see footnote

2021-06-04 16:31:02 -0400 2021-06-02 P 22,138 $18.77 a 4,965,769 indirect 1.4493 -2.2989 -13.5432 8.7956 15 -20.1399 27

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
89BIO INC ETNB 2021-07-28 16:45:03 UTC -0.5939 0.6739 75000
89BIO INC ETNB 2021-07-28 16:15:02 UTC -0.5939 0.6739 75000
89BIO INC ETNB 2021-07-28 15:45:03 UTC -0.5939 0.6739 75000
89BIO INC ETNB 2021-07-28 15:15:03 UTC -0.5939 0.6739 75000
89BIO INC ETNB 2021-07-28 14:45:02 UTC -0.4347 0.5147 75000
89BIO INC ETNB 2021-07-28 14:15:03 UTC -0.4347 0.5147 75000
89BIO INC ETNB 2021-07-28 13:45:02 UTC -0.4347 0.5147 75000
89BIO INC ETNB 2021-07-28 13:15:03 UTC -0.4347 0.5147 75000
89BIO INC ETNB 2021-07-28 12:45:03 UTC -0.4347 0.5147 75000
89BIO INC ETNB 2021-07-27 22:15:03 UTC -0.4347 0.5147 30000
89BIO INC ETNB 2021-07-27 21:45:03 UTC -0.4253 0.5053 30000
89BIO INC ETNB 2021-07-27 21:15:03 UTC -0.4253 0.5053 30000
89BIO INC ETNB 2021-07-27 20:45:03 UTC -0.4253 0.5053 30000
89BIO INC ETNB 2021-07-27 20:15:03 UTC -0.4253 0.5053 30000
89BIO INC ETNB 2021-07-27 19:45:02 UTC -0.4253 0.5053 30000
89BIO INC ETNB 2021-07-27 19:15:02 UTC -0.4253 0.5053 30000
89BIO INC ETNB 2021-07-27 18:45:03 UTC -0.4633 0.5433 30000
89BIO INC ETNB 2021-07-27 18:15:02 UTC -0.4633 0.5433 30000
89BIO INC ETNB 2021-07-27 17:45:03 UTC -0.4633 0.5433 30000
89BIO INC ETNB 2021-07-27 17:15:03 UTC -0.4633 0.5433 30000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Index Plus All-Cap Fund ETNB -4.0 shares, $-101.0 2020-03-31 N-PORT

Elevate your investments